ArticleTrials2022

Nicotinamide riboside as a neuroprotective therapy for glaucoma: study protocol for a randomized, double-blind, placebo-control trial.

Christopher Kai Shun Leung et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.